XML 158 R144.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Share-based compensation plan - Phantom shares plan ("PS") and Restricted Shares (Details) | 12 Months Ended |
--- | --- | ---
Dec. 31, 2024 BRL (R$) shares R$ / shares shares | Dec. 31, 2023 BRL (R$) shares R$ / shares | Dec. 31, 2022 BRL (R$)
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Share-based compensation plans | R$ | R$ 361,974,000 | R$ 268,489,000 |
Time to calculate the average price of shares based on recent trading sessions | 90 days |  |
PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Number of other equity instruments outstanding in share-based payment arrangement | 10,096,497 | 9,728,425 |
Granted during of the year | 2,981,547 |  |
Cancelled | 923,167 |  |
Exercised (1) | 1,690,308 |  |
Available for completion | 458,664 |  |
Restricted stock, year one | 3,591,140 |  |
Restricted stock, year two | 3,049,039 |  |
Restricted stock, year three | 2,793,223 |  |
Restricted stock, year four | 204,431 |  |
Share-based compensation plans | R$ | R$ 361,974,000 | R$ 268,489,000 | R$ 162,117,000
Stock options granted (Note 23) | R$ | 173,486,000 | 154,318,000 |
Decrease Provision Share Based Payment | R$ | R$ (80,001,000) | R$ (47,946,000) |
Phantom Share Units Psus |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Phantom Share Units Psus | R$ / shares | R$ 42.36 | R$ 58.07 |
Restricted share units |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Number of other equity instruments outstanding in share-based payment arrangement | 2,980,111 | 592,749 |
Granted during of the year | 3,392,475 |  |
Exercised (1) | 1,005,113 |  |
Restricted stock, year one | 453,265 |  |
Restricted stock, year two | 489,074 |  |
Restricted stock, year three | 417,772 |  |
Restricted stock, year four | 1,620,000 |  |
Share-based compensation plans | R$ | R$ 60,226,000 | R$ 26,744,000 | R$ 18,425,000
Stock options granted (Note 23) | R$ | 81,276,000 | 8,319,000 |
Decrease Provision Share Based Payment | R$ | R$ (47,794,000) |  |
Grant Year 2019 | PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 42.81 |
Number of other equity instruments outstanding in share-based payment arrangement |  | 39,461 |
Granted during of the year | 903 |  |
Cancelled |  |  |
Exercised (1) | 40,364 |  |
Available for completion |  |  |
Restricted stock, year one |  |  |
Restricted stock, year two |  |  |
Restricted stock, year three |  |  |
Restricted stock, year four |  |  |
Grant Year 2020 | PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 38.36 |
Number of other equity instruments outstanding in share-based payment arrangement | 33,384 | 984,160 |
Granted during of the year | 22,525 |  |
Cancelled | 204,963 |  |
Exercised (1) | 768,338 |  |
Available for completion | 33,384 |  |
Restricted stock, year one |  |  |
Restricted stock, year two |  |  |
Restricted stock, year three |  |  |
Restricted stock, year four |  |  |
Grant Year 2021 | PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 62.15 |
Number of other equity instruments outstanding in share-based payment arrangement | 874,480 | 1,724,020 |
Granted during of the year | 39,387 |  |
Cancelled | 66,231 |  |
Exercised (1) | 822,696 |  |
Available for completion | 425,280 |  |
Restricted stock, year one | 449,200 |  |
Restricted stock, year two |  |  |
Restricted stock, year three |  |  |
Restricted stock, year four |  |  |
Grant Year 2021 | Restricted share units |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 51.70 |
Number of other equity instruments outstanding in share-based payment arrangement |  | 111,685 |
Granted during of the year | 2,559 |  |
Exercised (1) | 114,244 |  |
Restricted stock, year one |  |  |
Restricted stock, year two |  |  |
Restricted stock, year three |  |  |
Restricted stock, year four |  |  |
Grant Year 2022 | PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 57.54 |
Number of other equity instruments outstanding in share-based payment arrangement | 3,461,437 | 3,686,722 |
Granted during of the year | 84,207 |  |
Cancelled | 286,478 |  |
Exercised (1) | 23,014 |  |
Available for completion |  |  |
Restricted stock, year one | 3,113,607 |  |
Restricted stock, year two | 324,611 |  |
Restricted stock, year three | 23,219 |  |
Restricted stock, year four |  |  |
Grant Year 2022 | Restricted share units |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 53.81 |
Number of other equity instruments outstanding in share-based payment arrangement | 115,800 | 113,161 |
Granted during of the year | 2,639 |  |
Exercised (1) |  |  |
Restricted stock, year one | 115,800 |  |
Restricted stock, year two |  |  |
Restricted stock, year three |  |  |
Restricted stock, year four |  |  |
Grant Year 2023 | PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 48.79 |
Number of other equity instruments outstanding in share-based payment arrangement | 3,052,179 | 3,294,062 |
Granted during of the year | 74,647 |  |
Cancelled | 283,548 |  |
Exercised (1) | 32,982 |  |
Available for completion |  |  |
Restricted stock, year one | 28,333 |  |
Restricted stock, year two | 2,721,535 |  |
Restricted stock, year three | 302,311 |  |
Restricted stock, year four |  |  |
Grant Year 2023 | Restricted share units |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 51.45 |
Number of other equity instruments outstanding in share-based payment arrangement | 383,568 | 367,903 |
Granted during of the year | 15,665 |  |
Exercised (1) |  |  |
Restricted stock, year one |  |  |
Restricted stock, year two | 268,534 |  |
Restricted stock, year three | 115,034 |  |
Restricted stock, year four |  |  |
Grant Year 2024 | PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 56.52 |
Number of other equity instruments outstanding in share-based payment arrangement | 2,675,017 |  |
Granted during of the year | 2,759,878 |  |
Cancelled | 81,947 |  |
Exercised (1) | 2,914 |  |
Available for completion |  |  |
Restricted stock, year one |  |  |
Restricted stock, year two | 2,893 |  |
Restricted stock, year three | 2,467,693 |  |
Restricted stock, year four | 204,431 |  |
Grant Year 2024 | Restricted share units |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Fair value on grant date | R$ |  | R$ 55.27 |
Number of other equity instruments outstanding in share-based payment arrangement | 2,480,743 |  |
Granted during of the year | 3,371,612 |  |
Exercised (1) | 890,869 |  |
Restricted stock, year one | 337,465 |  |
Restricted stock, year two | 220,540 |  |
Restricted stock, year three | 302,738 |  |
Restricted stock, year four | 1,620,000 |  |
SAR and PLUS | Top of range [member] | PSO |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Share-based compensation arrangement by share-based payment award, award vesting period | 5 years |  |
SAR and PLUS | Top of range [member] | Restricted share units |  |  |
Disclosure of terms and conditions of share-based payment arrangement [line items] |  |  |
Share-based compensation arrangement by share-based payment award, award vesting period | 5 years |  |

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of non-current provisions for employee benefits. [Refer: Provisions for employee benefits] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 1 -IssueDate 2024-01-01 -Paragraph 78 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2024-en-r&anchor=para_78_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NoncurrentProvisionsForEmployeeBenefits
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) forfeited in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsForfeitedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph b -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_b&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Represents share-based payment instruments that have met the vesting conditions and are available for completion but not yet exercised or transferred. + References No definition available. + Details
Name: | suz_AvailableForCompletionShareUnits
Namespace Prefix: | suz_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the decrease in the provision recognized for share-based payment transactions, specifically for cash-settled share-based compensation, such as phantom stock plans, due to exercised (settled) amounts. + References No definition available. + Details
Name: | suz_DecreaseProvisionShareBasedPayment
Namespace Prefix: | suz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Represents the increase in the provision recognized for share-based payment transactions, specifically for cash-settled share-based compensation, such as phantom stock plans. + References No definition available. + Details
Name: | suz_IncreaseProvisionShareBasedPayment
Namespace Prefix: | suz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Restricted Stock, Year Four + References No definition available. + Details
Name: | suz_RestrictedStockYearFour
Namespace Prefix: | suz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met. + References No definition available. + Details
Name: | suz_RestrictedStockYearOne
Namespace Prefix: | suz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Restricted Stock, Year Three + References No definition available. + Details
Name: | suz_RestrictedStockYearThree
Namespace Prefix: | suz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Restricted Stock, Year Two + References No definition available. + Details
Name: | suz_RestrictedStockYearTwo
Namespace Prefix: | suz_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period which the right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | suz_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod
Namespace Prefix: | suz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Time to calculate the average price of shares based on recent trading sessions + References No definition available. + Details
Name: | suz_TimeToCalculateTheAveragePriceOfSharesBasedOnRecentTradingSessions
Namespace Prefix: | suz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=suz_PSOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=suz_PhantomShareUnitsPsusMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ifrs-full_RestrictedShareUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | suz_VestingAxis=suz_GrantYear2019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | suz_VestingAxis=suz_GrantYear2020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | suz_VestingAxis=suz_GrantYear2021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | suz_VestingAxis=suz_GrantYear2022Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | suz_VestingAxis=suz_GrantYear2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | suz_VestingAxis=suz_GrantYear2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | suz_PlanNameAxis=suz_StockAppreciationRights2017AndStockAppreciationRightsPlus2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |